| Patents for A61K - Preparations for medical, dental, or toilet purposes (29,449) |
|---|
| 08/19/2004 | US20040162263 Pharmaceutical formulations targeting specific regions of the gastrointesinal tract |
| 08/19/2004 | US20040161425 Chemokine receptor antagonists as therapeutic agents |
| 08/19/2004 | US20040161392 Using salicylic acid derivative; side effect reduction |
| 08/19/2004 | CA2814767A1 Combination therapy for treating protein deficiency disorders |
| 08/19/2004 | CA2694872A1 Improved thickened beverages for dysphagia |
| 08/19/2004 | CA2515125A1 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515123A1 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515122A1 Immunogenic cd91 ligand-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515112A1 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515107A1 Immunogenic acute phase protein-antigenic molecule complexes and fusion proteins |
| 08/19/2004 | CA2515070A1 Novel compounds |
| 08/19/2004 | CA2514966A1 Antiglucocorticoids for the treatment of postpartum psychosis |
| 08/19/2004 | CA2514942A1 Methods and compositions for the treatment of parkinson's disease and other a-synucleinopathies |
| 08/19/2004 | CA2514642A1 Combination therapy for treating protein deficiency disorders |
| 08/19/2004 | CA2514641A1 Methods for modulating an inflammatory response |
| 08/19/2004 | CA2514576A1 Methods for treating, preventing and detecting helicobacter infection |
| 08/19/2004 | CA2514563A1 Inhibition of hiv-1 replication by disruption of the processing of the viral capsid-spacer peptide 1 protein |
| 08/19/2004 | CA2514334A1 Novel antiherpes drug combinations |
| 08/19/2004 | CA2513905A1 Immune regulation based on the targeting of early activation molecules |
| 08/19/2004 | CA2513722A1 Active immunization to generate antibodies to soluble a-beta |
| 08/19/2004 | CA2512867A1 Vitamin receptor binding drug delivery conjugates |
| 08/18/2004 | EP1446140A2 Treatment of severe pneumonia by administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446138A2 Treatment of sepsis by low dose administration of tissue factor pathway inhibitor (tfpi) |
| 08/18/2004 | EP1446131A1 Use of specific dose of fondaparinux sodium for the treatment of acs |
| 08/18/2004 | EP1446123A1 Rosuvastatin in pre demented states |
| 08/18/2004 | EP1446122A1 Use of flibanserin in the treatment of sexual disorders |
| 08/18/2004 | EP1446117A2 Treatment of acute myeloid leukemia with indolinone compounds |
| 08/18/2004 | EP1171085B1 Oral care composition |
| 08/18/2004 | EP0889720B1 Low residue antiperspirant stick composition |
| 08/18/2004 | EP0885006B1 Pharmaceutical composition enabling to inhibit cancer metastasis formation containing n-acetyl-cysteine and doxorubicin |
| 08/18/2004 | CN1522245A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obestity and type II diabetes |
| 08/18/2004 | CN1522150A Agent containing fat (oil), which contains onion extract, the production and use thereof for caring, preventing or treating damaged skin tissue, especially scarred tissue |
| 08/18/2004 | CN1522143A Coenzyme q and eicosapentaenoic acid (epa) |
| 08/17/2004 | US6777555 3-(optionally hydroxyl)-4-(cyclopropylcarbonyl)-cumene intermediate |
| 08/17/2004 | US6777552 From an ester derivative or protected ester derivative of the statin by using calcium hydroxide |
| 08/17/2004 | US6777543 13-methyl erythromycin derivatives |
| 08/17/2004 | US6777406 Substituted pyrroloquinolines and pyridoquinolines as serotinin agonists and antagonists |
| 08/17/2004 | US6777398 Process for the preparation of chondroitin sulfates from K4 polysaccharide and obtained products |
| 08/17/2004 | CA2133177C Rapamycin formulations for oral administration |
| 08/12/2004 | WO2004067698A2 Helminth-derived antigens having capacity of providing protection against parasites |
| 08/12/2004 | WO2004067025A1 Use of the cathelicidin ll-37 and derivatives thereof for wound healing |
| 08/12/2004 | WO2004066966A2 Peptide yy analogs |
| 08/12/2004 | WO2004066963A2 N-cyclohexylaminocarbonyl benzenesulfonamide derivatives |
| 08/12/2004 | WO2004066961A2 Use of sendai virus as a human parainfluenza vaccine |
| 08/12/2004 | WO2004066958A2 Caspase-9:bir3 domain of xiap complexes and methods of use |
| 08/12/2004 | WO2004066957A2 ANTI-INTEGRIN ανβ3 ANTIBODY FORMULATIONS AND USES THEREOF |
| 08/12/2004 | WO2004066955A2 Slowly digestible starch |
| 08/12/2004 | WO2004066954A2 A therapeutic composition for the treatment of hiv-1 and hiv-2 |
| 08/12/2004 | WO2004066953A2 Polymerized hemoglobin solutions having reduced amount of tetramer and method for preparing |
| 08/12/2004 | WO2004066952A2 Benzoxazole, benzothiazole, and benzimidazole derivatives for the treatment of cancer and other diseases |
| 08/12/2004 | WO2004066951A2 Quinoline derivatives as nk-2 and nk-3 receptor antagonists |
| 08/12/2004 | WO2004066948A2 Mapcaxs as modifiers of the apc and axin pathways and methods of use |
| 08/12/2004 | WO2004066946A2 Method for evaluating the efficacy of certain cancer treatments |
| 08/12/2004 | WO2004066944A2 Products for treating and preventing chronic diseases: eliminating the autoimmune triggers that underly chronic disease |
| 08/12/2004 | WO2004066943A2 Methods for diagnosis anf monitoring of neurological disease by detection of an encephalotoxin |
| 08/12/2004 | WO2004066942A2 Purification and uses of dendritic cells and monocytes |
| 08/12/2004 | WO2004066940A2 Compositions and methods containing substituted quinolines and substituted diphenylsulfones |
| 08/12/2004 | WO2004066938A2 Method and composition for lowering cholesterol |
| 08/12/2004 | WO2004066936A2 Method and assembly for liquid nitrogen therapy |
| 08/12/2004 | WO2004066935A2 Sensitive proteasome sensor constructs and methods for their design and use |
| 08/12/2004 | WO2004066933A2 Compositions and methods for treating cancer using igsf9 and liv-1 |
| 08/12/2004 | WO2004066932A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | WO2004066931A2 Composition for and treatment of demyelinating diseases and paralysis by administration of remyelinating agents |
| 08/12/2004 | WO2004066929A2 Cycloalkyl containing anilide ligands for the thyroid receptor |
| 08/12/2004 | WO2004066928A2 Use of mycobacterial vaccines in cd4+ or cd8+ lymphocyte-deficient mammals |
| 08/12/2004 | WO2004066926A2 Methods and compositions for modulating t lymphocytes |
| 08/12/2004 | WO2004066924A2 Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid |
| 08/12/2004 | WO2004066922A2 A method of treating breast cancer with androgen receptor antagonists |
| 08/12/2004 | WO2004066921A2 Erbb4 co-crystal |
| 08/12/2004 | WO2004066920A2 17-carbamoyloxy cortisol derivatives as selective glucocorticoid receptor modulators |
| 08/12/2004 | WO2004066917A2 Tandem analyses of noncovalently driven effectors for modulatory mapping of activities of protein sites |
| 08/12/2004 | WO2004066915A2 Old-35, a gene associated with senescence and terminal cell differentiation, and uses thereof |
| 08/12/2004 | WO2004066914A2 Variant integrin polypeptides and uses thereof |
| 08/12/2004 | WO2004066913A2 Solid mosapride preparation |
| 08/12/2004 | WO2004066912A2 Anti-inflammatory compositions and uses thereof |
| 08/12/2004 | WO2004066910A2 Controlled release modifying complex and pharmaceutical compositions thereof |
| 08/12/2004 | WO2004054504A3 Tricyclic aminocyanopyridine inhibitors of mitogen activated protein kinase-activated protein kinase-2 |
| 08/12/2004 | WO2004052280A3 Anti-angiogenic compounds and their use in cancer treatment |
| 08/12/2004 | WO2004050019A3 Method and compositions for treating anxiety |
| 08/12/2004 | WO2004045559A3 Method for the prevention of malaria |
| 08/12/2004 | WO2004045557A3 Novel lapachone compounds and methods of use thereof |
| 08/12/2004 | WO2004045545A3 Compositions and methods for the treatment of cancer, screening of putative anti-cancer compounds, and assessing cancer progression |
| 08/12/2004 | WO2004043362A3 Acyl guanidine compounds and use thereof |
| 08/12/2004 | WO2004041182A3 M. haemolytica outer membrane protein plpe as a vaccine or vaccine component against shipping fever |
| 08/12/2004 | WO2004032880A3 Method for inhibiting angiogenesis with ship-1 inhibitors |
| 08/12/2004 | WO2004032860A3 Hiv vaccine formulations |
| 08/12/2004 | WO2004016222A3 Hepatitis c viral-like particle purification |
| 08/12/2004 | WO2003103592A3 Covalent conjugates between artemisinin-related endoperoxides and iron-carrying proteins and methods of use |
| 08/12/2004 | WO2003086297A3 Multi-layer mucoadhesive drug delivery device with bursting release layer |
| 08/12/2004 | WO2003057133A9 Herbal composition for treating various disorders including psoriasis, a process for preparation thereof and method for treatment of such disorders |
| 08/12/2004 | US20040157927 Pharmaceutical combination comprising either (s)-2-ethoxy-3-[4-(2-{4-methane sulfonyl oxyphenyl} ethoxy) phenyl] propanoic acid or 3-{-4-[2-(4-tert-butoxy carbonyl aminophenyl) ethoxy] phenyl}-(s)-2-ethoxy propanoic acid and a sulonylurea |
| 08/12/2004 | US20040157893 Pyrazole compounds useful as protein kinase inhibitors |
| 08/12/2004 | US20040157889 Potassium and sodium channel moderators; brain disorders; strokes; multiple sclerosis |
| 08/12/2004 | US20040157888 Method of treating of demyelinating diseases or conditions |
| 08/12/2004 | US20040157886 Brain disorders; central nervous system disorders; viricides |
| 08/12/2004 | US20040157718 Method and apparatus for sterilizing internal passages of a centrifuge centrate gate |
| 08/12/2004 | US20040157330 Compositions and methods for targeted biological delivery of molecular carriers |
| 08/12/2004 | US20040157251 Detecting amount in sample (blood, plasma, or urine) using immunoassay, mass spectrometry or polymerase chain reaction to determine mRNA levels |
| 08/12/2004 | US20040156932 Tetrahydroberberine (THB), l-Tetrahydropalmatine (l-THP) and l-Stepholidine (l-SPD),isolated from Magnoliidae plants, decrease nicotine dependence, alcohol abuse, cocaine abuse and opiate dependence in humans. treatment for Parkinson's Alzheimers, |
| 08/12/2004 | US20040156865 M. haemolytica outer membrane protein P1pE as a vaccine or vaccine component against shipping fever |